biote Interim CEO granted 206,746 stock options

biote Corp. interim CEO Robert Charles Peterson received a grant of stock options as part of his compensation.

Rhea-AI Filing Summary

biote Corp. interim CEO Robert Charles Peterson received a grant of stock options as part of his compensation. The award covers 206,746 options to purchase Class A common stock at an exercise price of $2.46 per share and expires on June 11, 2036. According to the vesting terms, 25% of the options will vest on June 12, 2027, with the remaining options vesting in 36 substantially equal monthly installments, subject to his continued service. Following this grant, Peterson holds 206,746 stock options directly, and the filing does not report any open-market share purchases or sales.

Insider Trade Summary

Grant/Award: 206,746 shares

Grant/Award 1 txn

Insider Peterson Robert Charles

Role Interim CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to buy)	206,746	$0.00	$0.00

Holdings After Transaction: Stock Options (Right to buy) — 206,746 contracts (Direct)

Footnotes (1)

1. F1. 25% of the shares subject to the option shall vest on June 12, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Key Figures

Options granted: 206,746 options Exercise price: $2.46 per share Options outstanding after grant: 206,746 options +3 more

6 metrics

Options granted 206,746 options Grant to Interim CEO on June 12, 2026

Exercise price $2.46 per share Stock options strike price

Options outstanding after grant 206,746 options Total derivative holdings following transaction

Expiration date June 11, 2036 Stock options expiration

Initial vesting milestone 25% on June 12, 2027 Cliff vesting portion of options

Remaining vesting schedule 36 monthly installments Balance of options vesting after June 12, 2027

Key Terms

Stock Options (Right to buy), Class A Common Stock, exercise price, vesting

4 terms

Stock Options (Right to buy) financial

"security_title: Stock Options (Right to buy)"

Class A Common Stock financial

"underlying_security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

exercise price financial

"conversion_or_exercise_price: 2.4600"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"25% of the shares subject to the option shall vest on June 12, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did biote Corp. (BTMD) report for Robert Charles Peterson?

biote Corp. reported that Interim CEO Robert Charles Peterson received 206,746 stock options as a compensation grant. These derivative securities give him the right to buy Class A common stock at a fixed exercise price of $2.46 per share.

Is the June 12, 2026 Form 4 for BTMD a stock purchase or sale?

The Form 4 reports a stock option grant, not an open-market purchase or sale. Peterson was awarded options for 206,746 underlying shares at a $2.46 exercise price, with no cash transaction in the company’s stock market float.

What are the vesting terms of Robert Peterson’s 206,746 BTMD stock options?

The options vest over time: 25% of the shares vest on June 12, 2027. The remaining options then vest in 36 substantially equal monthly installments, subject to Peterson’s continuous service with biote Corp. through each vesting date.

When do Robert Peterson’s BTMD stock options expire?

The stock options granted to Robert Peterson expire on June 11, 2036. After that expiration date, any unexercised options will lapse, meaning he would no longer have the right to buy the corresponding Class A common shares at $2.46 per share.

How many BTMD stock options does Robert Peterson hold after this grant?

After this grant, Peterson holds 206,746 stock options directly. Each option relates to one share of Class A common stock at a $2.46 exercise price, and the options are subject to the specified vesting schedule running from June 2027 onward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peterson Robert Charles

(Last) (First) (Middle)

C/O BIOTE CORP.

1875 W. WALNUT HILL LN #100

(Street)

IRVING TEXAS 75038

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
biote Corp. [ BTMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	$2.46	06/12/2026		A		206,746		(1)	06/11/2036	Class A Common Stock	206,746	$0.00	206,746	D

Explanation of Responses:

1. 25% of the shares subject to the option shall vest on June 12, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

	/s/ Kendal McNeely, as Attorney-in-Fact for Peterson, Robert Charles	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)